Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

about

Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus.

P2860

Q38837001-3FDD57DD-B7C5-43B6-815D-BDFBD7DC8DBE

P2860

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Item

http://www.wikidata.org/entity/Q36913132

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

@en

type

Item

label

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

@en

prefLabel

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

@en

P1476

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

@en

P2093

Alberto Pugliese

http://www.w3.org/2001/XMLSchema#string

Jay S Skyler

http://www.w3.org/2001/XMLSchema#string

P2860

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

Type 1 Diabetes TrialNet--an international collaborative clinical trials network

Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation

Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential.

Update on worldwide efforts to prevent type 1 diabetes.

P304

S2-13-S2-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/DIA.2013.0107

http://www.w3.org/2001/XMLSchema#string

P478

15 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23786294

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

immunotherapy

P932

3676656

http://www.w3.org/2001/XMLSchema#string

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

about

P2860

P2860

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932